Britannia Life Sciences Inc. reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported net loss was CAD 0.054341 million compared to CAD 9.97 million a year ago.
For the nine months, net income was CAD 4.52 million compared to net loss of CAD 10.14 million a year ago. Basic earnings per share from continuing operations was CAD 0.03 compared to basic loss per share from continuing operations of CAD 0.11 a year ago.